As of Thursday close, China Pharma Holdings Inc.’s (AMEX:CPHI) stock was down -$0.05, moving down -23.44 percent to $0.16. The average number of shares traded per day over the past five days has been 1,827,660 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0695 fall in that time frame. In the last twenty days, the average volume was 2,005,075, while in the previous 50 days, it was 906,188.
Since last month, CPHI stock retreated -50.00%. Shares of the company fell to $0.1104 on 08/28/23, the lowest level in the past month. A 52-week high of $2.46 was reached on 01/12/23 after having rallying from a 52-week low of $0.11. Since the beginning of this year, CPHI’s stock price has dropped by -83.32% or -$0.7990, and marked a new high 4 times. However, the stock has declined by -93.49% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
The stock’s beta is 0.51. Besides these, the trailing price-to-sales (P/S) ratio of 0.24, the price-to-book (PB) ratio of 0.36.
Financial Health
In the three months ended September 29, China Pharma Holdings Inc.’s quick ratio stood at 0.20, while its current ratio was 0.50, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is -0.80% percent. In the year ended September 29, operating margins totaled -33.40%. Based on annual data, CPHI earned -$0.49 million in gross profit and brought in $8.1 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -33.80%. Return on equity (ROE) for the past 12 months was -77.40%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. CPHI’s revenue fell -46.36% to $1.96 million during the quarter, while net income inched up to $1.1 million. While analysts expected China Pharma Holdings Inc. to report $1.2 quarterly earnings, the actual figure was $0.8 per share, beating the consensus estimate by -33.30%. During the quarter, the company generated $0.24 million in EBITDA. The liabilities of China Pharma Holdings Inc. were 11.35 million at the end of its most recent quarter ended September 29, and its total debt was $7.79 million. The value of shareholders’ equity is $11.43 million.
Technical Picture
This quick technical analysis looks at China Pharma Holdings Inc.’s (CPHI) price momentum. With a historical volatility rate of 215.37%, the RSI 9-day stood at 24.96% on 31 August.
With respect to its five-day moving average, the current China Pharma Holdings Inc. price is down by -30.28% percent or -$0.0695. At present, CPHI shares trade -41.94% below its 20-day simple moving average and -52.93% percent below its 100-day simple moving average. However, the stock is currently trading approximately -57.44% below its SMA50 and -86.51% below its SMA200.
Stochastic coefficient K was 34.32% and Stochastic coefficient D was 35.08%, while ATR was 0.0632. Given the Stochastic reading of 20.33% for the 14-day period, the RSI (14) reading has been calculated as 28.27%. As of today, the MACD Oscillator reading stands at -0.0347, while the 14-day reading stands at -0.0338.
Analyst Ratings
Rodman & Renshaw launched its rating on China Pharma Holdings Inc. (AMEX: CPHI) to a Mkt outperform in a note to investors on January 08, 2010. China Pharma Holdings Inc. (CPHI) has been rated Buy by analysts. According to 0 brokerage firms, CPHI is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate China Pharma Holdings Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $45.00, the current consensus forecast for the stock is $45.00 – $45.00. Based on these forecasts, analysts predict China Pharma Holdings Inc. (CPHI) will achieve an average price target of $45.00.
